RTsafe joins King’s College’s London Institute for Healthcare Engineering

Athens, November 21, 2023

RTsafe, the Athens, Greece-based leader in personalised radiation therapy Quality Assurance, will be joining the London Institute for Healthcare Engineering (LIHE) of King’s College London.  The institute seeks to bring together world-class research and development expertise across academia, the NHS, and medical technology (MedTech) companies.

LIHE’s mission is to transform patient care by creating a seamless pipeline of innovation, from conception to commercialisation, enabling early adoption of cutting-edge technology throughout the NHS. RTsafe is a medical technology company operating globally that has developed a unique approach to quality assurance that is making a contribution to the safety and accuracy of radiotherapy for cancer and other medical conditions.

The institute provides a physical space within London’s St Thomas’ Hospital campus for start-ups, small and medium-sized enterprises (SME’s), and multinational companies that together will ensure that the latest medical technology and discoveries are translated swiftly and effectively into patient care. RTsafe will be the first MedTech SME to join the institute.

Dr Evangelos Pappas, founder and CEO, RTsafe, said:

“As RTsafe is expanding globally, we have been looking for expert partners to support us on our growth journey. Joining LIHE was a natural choice as we are building our presence in the UK. The opportunities for research, clinical and commercial collaborations that LIHE offers will prove invaluable to our long-term growth and success. I am also looking forward to contributing to LIHE’s ecosystem by sharing my personal experience with other MedTech founders on their own journey.”

Dr Nicolas Huber, Director of Commercial Operations and Partnerships at LIHE, said:

“It is a testament to our vision of creating the UK’s first vertically integrated MedTech ecosystem that RTsafe, an international scale-up on a mission to make radiation therapy safe for all patients, has made the decision to join LIHE as our first SME member. I welcome Dr Pappas and his team, and we are looking forward to drawing on their expertise to support the early-stage MedTech companies we will be hosting at LIHE.”

About RTsafe

RTsafe is a medical technology company that has developed a unique approach to quality assurance that significantly enhances the safety and accuracy of radiotherapy for cancer and other medical conditions. It combines proven expertise in medical physics with highly accurate 3D printing technology to create pseudo‐in‐vivo dosimetry phantoms towards End‐to‐End commissioning, benchmarking and patient‐specific quality assurance in SRS, IMRT, VMAT and SBRT applications. The anatomically accurate effigies enable medical professionals to plan more precise treatment interventions for each individual patient and help radiotherapy technology innovators to fine‐tune their products. The result is more effective individualized therapy and reduced patient risk.

For more information, visit www.rt-safe.com.

About LIHE

The London Institute for Healthcare Engineering (LIHE), a collaboration project led by King’s College London’s School of Biomedical Engineering & Imaging Sciences uniquely dedicated to MedTech translation. The institute is designed to bring together King’s College’s research excellence, leading clinical practice from Guys and St Thomas’s Hospital Trust, and the MedTech sector’s commercial power and innovation. It also provides physical collocation space for start-ups, SME’s and multinational companies.

See https://www.kcl.ac.uk/bmeis/london-institute-for-healthcare-engineering